You have already chosen the sequence. The harder decision comes next: where the label sits, which linker connects the peptide to the nanomaterial, and what the…
He aha nā ʻano nanobiosensor e koi maoli ai mai kahi mea ʻike
Kūʻai kūʻai nui ʻo PeptidesPeptid Epartnters Ke koi nei kahi nanobiosensor i ʻehā mau mea mai kāna mea ʻike i ka manawa hoʻokahi: he hanana hoʻopaʻa a ʻokiʻoki paha e hoʻololi i kahi hōʻailona hiki ke ana, he kuhikuhi i hoakakaia ma ka ili, kūpaʻa kūʻē i ka fouling a me ke keakea matrix, a me ka hōʻailona e noho like ana mai ka hailona a i ka hailona. E haʻalele i kekahi a hāʻule ka assay ma ke ʻano he pilikia biology akā maʻamau he pilikia kemika.
Hōʻike ka moʻolelo i paʻi ʻia i ka nui o ke ʻano o ke ʻano o ke koi. Ua helu ʻo Negahdary lāua ʻo Angnes i kēia mau mea ʻike e ka papa kuhikuhi a loiloi i kēlā me kēia ma ka analyte, kaʻina peptide, pāʻani pūʻulu hana, mea nano, ʻenehana ʻike, laula ʻike, palena o ka ike, a me ke ʻano a me ke kūlana o ka hōʻailona redox (PubMed, 2022). ʻO kēlā papa inoa he papa inoa kikoʻī: ʻO kēlā me kēia o kēlā mau palena e hoʻi i kahi hoʻoholo i hana ʻia i ka wā i kauoha ʻia ai ka peptide.
ʻO nā palena o ka ʻike i hōʻike ʻia ma kahi ākea nui, ʻo ia ke kumu e haʻi liʻiliʻi ai ka helu ʻike ʻole. ʻO kahi hoʻohālikelike i hoʻohālikelike ʻia o nā sensor electrochemical e pili ana i ka peptide e papa inoa i ka PSA ma 3.2 fM ma kahi electrode gula me ka hoʻonui ʻana i ka ATRP i hoʻopili ʻia me ka electrochemically, MMP-14 ma 0.1 ng/L me kahi peptide lawe ferrocene, a me MMP-7 ma 3.1 fg/mL ma ke kalapona aniani me ka palladium nanoparticle probes (Biosensors, 2021, Papakaukau 1). He mau analytes ʻokoʻa kēia ma nā paepae like ʻole, no laila, ʻaʻole lākou he hoʻohālikelike like-no-like; ʻO ka mea a lākou e kaʻana ai, ua hoʻolālā ʻia ka lepili a me ka heleuma o ka peptide no ke ala transduction kikoʻī.
Hoʻonui ʻia ka hoʻopiʻi ʻana. A 2026 ʻO ka nānā ʻana i ke kumu i hāʻule ʻole ai nā mea ʻike i nā laʻana olaola e wehewehe ana i ka fouling ma ke ʻano he adsorption nonspecific a me ka hōʻiliʻili ʻana o nā ʻano mea makemake ʻole ma ka interface wai-paʻa., ka mea e ālai ana i ka hoʻoili electron a hōʻemi i ka hiki ke loaʻa (Int J Mol Sci, 2026). ʻO kahi loulou a me ka lepili i koho wale ʻia no ka ikaika hōʻailona, me ka noʻonoʻo ʻole i ka papa waena, e lilo i ka fouling i loko o ka serum ma mua o ka hoʻāʻo ʻia ʻana o ke kemika paʻa.
No ke aha he peptide ma kahi o kahi antibody a i ʻole aptamer - a he aha kāna hana
E koho i nā peptides, nā antibodies a i ʻole nā mea ʻike ʻē aʻe mai ka pilina, koho, hiki ke komo, kemika a me ka hana ho'āʻo. Hiki ke ʻike ʻia nā antibody ma o ka hōʻike a me nā ʻano hana ʻē aʻe; ʻAʻole i hana ʻia ko lākou mau wahi paʻa ma o ka lāʻau lapaʻau wale nō.
ʻAʻohe cysteine i loko o ka SFIIDGPNTEPEK kaʻina i ʻōlelo ʻia he 13 koena. No laila, pono ke koena a i ʻole ka lima i hoʻopili ʻia i ka cysteine-mediated surface, pono e hōʻike ʻia ma ka ʻōlelo kikoʻī a me ka moʻolelo ʻike.
ʻO ka hana a ka peptide e hoʻoholo ai i ka mea e hana ai ka lepili:
Ki Takeaway
ʻElemu hopu: paʻa ka peptide i ka pahu hopu a hele mai ka hōʻailona mai kahi hoʻonā redox probe a i ʻole impedance. He haʻahaʻa ka makemake lepili, akā ʻo ka orientation a me ka antifouling ka mea nui loa.
Pākuʻi Protease: hoʻokuʻu ʻo cleavage i kahi ʻāpana redox-tag. Pono e noho ka tag i kahi e wehe ai ka cleavage mai ka electrode, a pono e hoʻopaʻa ʻia ke kaʻina mahele.
ʻimi FRET: e noho ana ka fluorophore a me ke kinai ma na aoao o ke kahua mahele. Pono e hoʻokomo ʻia nā lepili ʻelua ma kahi pūnaewele a i ʻole he hewa ka hōʻailona kumu.
ʻO ka hoʻopaʻa ʻana a i ʻole ka ligand reporter: ʻo ka lepili ka heluhelu ʻana. Hoʻoholo ke kūlana o ka lepili a me ke kūlana lepili i ka mālamalama a me ka kikoʻī.
ʻO kahi haʻawina spacer-lōʻihi i hoʻohālikelike ʻia i ka PEG-2 ma o ka PEG-12 e hōʻike ana i ka nui o kēia hoʻolālā e hiki ke hoʻohālikelike ʻia.: ke kaʻina mahele like, methylene blue tag, ʻO ka heleuma cysteine a me ka D-amino acid controls i hana i nā hana like ʻole ma muli o ka spacer wale nō (ʻImi ʻImi ʻEdinburgh, 2017). No laila ʻoi aku ka liʻiliʻi o ka peptide synthesis no nā biosensors e pili ana i ka hana ʻana i ke kaʻina a ʻoi aku ka nui o ka hana ʻana i ke kaʻina me nā lima kūpono i nā wahi kūpono..
No ke aha e ʻoi aku ai ka hōʻailona kikoʻī o ka pūnaewele i ka lepili helu helu - a me nā koena āu e hiki ai ke lepili
Lanakila ka lepili kiko'ī pūnaewele no ka mea e wehe ana i nā isomers kūlana mai ka hoohalike. Lepili helu helu, kahi e hana ai ka reagent me kēlā me kēia lysine a i ʻole cysteine i hiki ke loaʻa, hana i ka hui ʻana o nā conjugates i ʻokoʻa ma kahi e noho ai ka lepili. Hana ʻia kēlā hui ʻana ma ke ʻano he mahele, ʻaʻole he hui, a hiki ke hoʻololi i kona haku mele ma waena o nā hailona ʻoiai ke ʻano like ka helu maʻemaʻe.
Hoʻonohonoho ka kemika āu e koho ai i ka nui o ka mana e loaʻa iā ʻoe. Hoʻokumu ʻia ka cycloaddition azide-alkyne copper-catalyzed i kahi 1,2,3-triazole paʻa a holo me nā helu maʻamau maʻamau ma waena. 10 a me 10⁴ M⁻¹s⁻¹, ʻoiai ʻo SPAAC ʻole keleawe me kahi paʻa DBCO e hilinaʻi nei i ke kani kani o kahi 18 kcal/mol a holo mālie ʻelua a ʻehā mau kauoha o ka nui (Biosensors, 2026). ʻO ka loiloi like he blunt e pili ana i ke koho maʻamau: ʻO ka hui pū ʻana o EDC/NHS i nā lysines e hāʻawi i ka orientation random, nā mea waena hydrolytically unstable, a ālai ʻia i nā pūnaewele hana. ʻO ka glutaraldehyde o ka dengue protocol e hoʻopili ana ma o nā pūʻulu amine kekahi ala ʻē aʻe., a ʻoiai ua hōʻike ʻia kēlā haʻawina i ka hana hou ʻana, ʻaʻole ia i hoʻopuka i ka orientation.
No ke kōkua
Cysteine: maleimide coupling, iodoacetamide, a i ʻole ka hoʻokumu ʻana i ka disulfide, koho ʻia no kahi loulou paʻa a i ʻole cleavable. ʻOi aku ka maikaʻi inā loaʻa i ka sequence hoʻokahi cysteine hiki iā ʻoe ke kau.
ʻO Lysine: NHS-ester a i ʻole EDC/NHS. Maikaʻi akā helu helu ke ʻole hoʻokahi lysine i hōʻike ʻia.
ʻO Azide a i ʻole ka lāʻau alkyne: CuAAC no ka wikiwiki, SPAAC kahi e hōʻino ai ke keleawe i ka ʻili a i ʻole ka bioreceptor.
N-kumu: koho acylation a reductive amination ke makemake ʻoe i ka lepili ma ka hope loa loa mai ka maka paʻa.
ʻO ka hopena kūpono ʻo ka hoʻoheheʻe ʻana o ka puʻupuʻu. Inā he helu maʻemaʻe hoʻokahi kāu kumu hoʻokuʻu, Hiki i nā ʻāpana ʻelua me nā meheu HPLC like ke lawe i nā helu lepili awelika like ʻole a me nā māhele kūlana ʻokoʻa, a neʻe pū ka hōʻailona sensor me lākou.
Pehea e koho ai i kahi loulou no ka immobilization ʻili ma kahi nanomaterial
E koho i ka mea hoʻopili e pili ana i kāna hana ma ka interface, ʻaʻole ma ka mea i loko o ka puke. Hoʻopaʻa kahi mea hoʻopili i ka peptide ma kahi mamao loa mai ka ʻili e hiki ai i ka pahu hopu, pale i ka adsorption nonspecific, a noho ma waho o ka hōʻailona pono'ī. Ke huki nei kēlā mau hana ma nā ʻaoʻao like ʻole, ʻo ia ke kumu o ka spacer maikaʻi loa i waena o ka lōʻihi ma mua o ka lōʻihi loa i loaʻa.
ʻO kahi haʻawina spacer-lōʻihi i hoʻohālikelike ʻia i ka PEG-2 ma o ka PEG-12 ma kahi sensor protease e hana ai i ke koʻikoʻi trade-off.. Ua hiki ka probe PEG-4 i ka palena haʻahaʻa trypsin o ka ʻike ma 88 pM, kūʻē 250 pM no PEG-2, ʻoiai ka PEG-8 a me ka PEG-12 probes i hoʻopuka i nā au kiʻekiʻe mua ma ka liʻiliʻi ʻelua ma lalo a ʻo kahi alkyl 8-aminooctanoic acid spacer i hāʻawi i ka haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa o nā hoʻokolohua āpau i hoʻāʻo ʻia. (ʻImi ʻImi ʻEdinburgh, 2017). E mālama i kēlā mea maikaʻi loa ma ke ʻano he kuhiakau hoʻomaka no kāu ʻōnaehana ponoʻī: hele mai ia mai kahi haʻawina mua ma hoʻokahi hōʻike protease, pela ka ili, ka nui o ka pahu hopu a hoʻopaʻa i nā neʻe a pau ma kahi e noho ai ka piko.
Hoʻopili ka ʻaoʻao kemika i ke kula ma mua o ka mea nui. Hāʻawi pōkole ʻo Ahx a me Gly-Ser, hiki ke hiki; Hoʻohui ka PEG i ka antifouling a lōʻihi ka hiki; Hāʻawi ka lāʻau biotin-streptavidin i kahi paʻa noncovalent ikaika e kūpono i nā ʻōkuhi i hōʻailona mua ʻia; Hāʻawi ka maleimide-Cys i kahi pilina covalent thiol; Hāʻawi kāna-tag / Ni-NTA i kahi hoʻololi. Ma kahi e hoʻokuʻu ai ka naʻau keleawe i ka CuAAC, ʻO ka cycloaddition azide–alkyne i hoʻoikaika ʻia i ke kānana a i ʻole ka lāʻau azide/alkyne i hui pū ʻia me kahi ala keleawe-ʻole e mālama i ka peptide..
Pehea e wehewehe ai i ka maemae, ʻike ʻike, degere o ka lepili, maʻiʻo a me ke ʻano kūʻē
ʻO ka pākēneka maʻemaʻe wale nō ʻaʻole ia he kikoʻī. ʻO ka wehewehe ʻana o ICH Q6B i kahi kikoʻī he papa inoa o nā hoʻokolohua, kuhikuhi i nā kaʻina hana kālailai, a me nā pae ʻae kūpono i hāʻawi ʻia ma ke ʻano he palena helu a i ʻole nā pae (Planet Peptides href="https://ntp.niehs.nih.gov/sites/default/files/iccvam/methods/biologics/vaccine/ich-q6b.pdf”>I Q6B, 1999). ʻElima mau hiʻohiʻona i loko o kahi kikoʻī-peptide, a pane kēlā me kēia nīnau i nā mea ʻē aʻe.
ʻElua o kēia mau mea e pono ai ke koʻikoʻi. ʻO ka ʻōlelo a Q6B e manaʻo pinepine ʻia ka maʻemaʻe e ka hui pū ʻana o nā ʻano hana e hōʻike ana i ka hoʻomaʻemaʻe piha ʻana i ke ala., a pili ka loina like i ka peptide synthetic. Pono ka ʻike i kahi hoʻāʻo kikoʻī loa, a ʻoi aku paha ka mea e pono ai. Hōʻike nā monographs peptide USP e like me teriparatide a me ka octreotide i ke ʻano o ke ʻano o ka palapala palapala piha.: nā ʻano i hoʻopaʻa ʻia, ʻae ʻae, a me nā mea kuhikuhi kikoʻī (USP, nā lā monograph 2023 i 2025).
ʻŌlelo aʻo ʻAʻole hiki i kahi helu maʻemaʻe HPLC hoʻokahi ke pani i nā ʻano ʻehā ʻē aʻe. Elua hailona ma 95% ʻokoʻa ka maʻemaʻe i ka helu lepili, ʻano paʻakai a me ka wai, a hiki i kekahi o ia mau mea ke hoʻoneʻe i kāu baseline sensor.
E mālama i nā māka maʻemaʻe ma ke ʻano he ʻaha kūkā, ʻaʻole kahi paepae hana i hoʻopaʻa ʻia. ʻAʻohe kumu kūʻokoʻa a mākou e hilinaʻi ai ma nā mokuʻāina i kahi pilina nui ma waena o ka pae maʻemaʻe HPLC a me ka hana hoʻāʻo, no laila e koho i kāu māka mai ka mea a ka assay e ʻae a hōʻoia i kāu ʻikepili ponoʻī.
ʻO ka pūʻolo analytical e hōʻike ana i ka peptide i kapa ʻia ʻo ia ka mea a ka CoA e ʻōlelo ai
Hōʻike ka palapala hōʻoia i ka peptide inā loaʻa nā hopena āpau i ke ʻano i hana ai a hiki ke loiloi ʻia ka ʻikepili ma hope o kēlā ʻano.. He CoA e helu ana i ka "maʻemaʻe: 96.2%” me ke kolamu ʻole, gradient, ʻO ka lōʻihi nalu a i ʻole ka maʻamau kuhikuhi he koi, aole hoike.
ʻO ka hōʻoia ʻana o ke ala ka papa mua. ʻO ka 2024 Hoʻonohonoho ka loiloi o ICH Q2 i nā loina hōʻoia no nā kaʻina hana loiloi, me ka hoʻohana ʻana i ka ʻikepili spectroscopic, a ua hoʻopau ʻia me ka Q14 i Malaki 2024 (FDA, 2024). No kahi peptide i hōʻailona ʻia, ʻo ia hoʻi, pono e hōʻike ʻia ke ʻano kikoʻī o kāu ʻano HPLC no nā ʻano i hoʻopaʻa ʻia e kūʻē i ka precursor i hōʻailona ʻole ʻia, ʻaʻole i manaʻo ʻia.
ʻO ka hoʻopaʻa pono ʻana ka papa lua. ʻO ke koʻikoʻi o ka loiloi loiloi ma 21 CFR 11.10(e) kahea no ka palekana, hana kamepiula, nā ala hoʻokele manawa, a ʻaʻole pono e hūnā i nā hoʻololi moʻolelo i ka ʻike i hoʻopaʻa ʻia ma mua (eCFR, kikokiko i kēia manawa). E pili ana paha i ka ʻōnaehana ʻikepili o ka mea hoʻolako i nā lula predicate, a me ka FDA 2003 alakaʻi ākea ma Part 11 e wehewehe ana ʻaʻole hiki i kahi kamepiula i hoʻohana wale ʻia no ka hana ʻana i nā paʻi pepa (FDA, 2003). E nīnau i ka mea e pili ana i nā moʻolelo āu e hilinaʻi ai.
ʻElua mau hoʻokolohua hou aʻe i loko o ka pūʻolo kahi e pono ai ka noi iā lākou. Hāʻawi ka mokuna endotoxin USP harmonized i ka hoʻāʻo endotoxins bacteria, oihana mai 2012 me ka hoʻāʻo ʻana i ka palena o ka gel clot ma ke ʻano o ka referee (USP, 2012), a me ka ho'āʻo sterility USP ⟨71⟩ he ala hele ʻole a ʻaʻole hōʻike i ka nele o kēlā me kēia microorganism. (USP, mokuna o keia manawa). No ka hooiaio nui, E hoʻomaopopo ʻoe hiki ke hoʻopili ʻia nā kikoʻī MALDI-TOF o nā peptides e ka trifluoroacetic acid matrix., no laila ʻo ke ala ʻelua e like me ESI-MS/MS e hoʻoikaika i nā koi ʻike.
Pehea ka hoʻololi ʻana o MOL Changes a me ka pae ʻāina QC i kahi kikoʻī-peptide i hōʻailona ʻia
Hiki i nā hoʻolālā Nanobiosensor ke koi i nā kūlana lepili pololei a me ke kemika o luna. Hōʻike nā laʻana i ʻōlelo ʻia i nā koi ʻenehana, ʻaʻole ka piʻi nui ʻana o ka noi peptide pāʻoihana a i ʻole ke ana ʻana i nā nīnau o nā mea kūʻai aku.
ʻO ka papa hana kemika ma nā koena i kūkākūkā ʻia ma luna. ʻO ka hana kikoʻī Cysteine e pili ana i ka hui maleimide, iodoacetamide a me ka lepili haloacetyl, a me ka hana disulfide me ka mana scrambling, koho ʻia e like me ka mea e pono ai ʻoe i kahi paʻa a i ʻole kahi loulou cleavable. ʻO Lysine-selective amine chemistry a me tyrosine-selective phenol chemistry e uhi i nā lima maʻamau., a me nā peptides hiki ke kaomi me ka azide a i ʻole nā lima alkyne e kākoʻo i nā ala CuAAC a me SPAAC.
Ma ka ʻaoʻao analytical, Hoʻohana ka hoʻokuʻu QC maʻamau i ka HPLC a me MALDI-MS, Kākoʻo ʻia e ka ʻike peptide net e ka nānā ʻana i ka waikawa amino a i ʻole CHN, ka wai a me ka ʻakika, mea kūʻē, ESI-MS/MS a me ka nānā ʻana i ka endotoxin. Pili kēlā palapala ʻāina i ka ʻōlelo kikoʻī ʻelima mau mea ma luna, me ka hoʻohui ʻana i ka hōʻoia ʻike orthogonal. Ke hoʻouna ʻoe i kahi kaʻina, ʻO nā kikoʻī e ʻae iā mākou e haʻi pololei i ka mokuʻāina terminal, ka hoʻololi a i ʻole ka lima (a i ʻole he noi ʻōlelo paipai), ke kūlana ma N-terminus, koena index a i ʻole C-terminus, ka nui a me ka maʻemaʻe pahuhopu me ka manaʻo hoʻohana, a me nā kaohi e like me ka cysteine hoʻokahi a i ʻole ke koi ʻana e pale i ka lepili lehulehu.
Pehea e kākau ai i ka kikoʻī a hoʻoholo i ka hoʻokuʻu
Kākau i ka ʻōlelo kikoʻī ma ke ʻano he hoʻonohonoho ʻae ʻana i hoʻopaʻa ʻia i ka assay, a laila hoʻokuʻu ma ka pūʻolo pili ma mua o ka hopena hoʻokahi. He maʻalahi kā mākou lula: inā ʻaʻole hiki ke ʻimi ʻia kahi hopena i kahi ala, kahi maʻamau a me kahi ala hoʻokele, ʻaʻole helu i ka hoʻokuʻu ʻana.
E wehewehe i ke kaʻina, hope, kūlana hōʻailona, linker a me ka hoʻohana i manaʻo ʻia. No ke kūkulu ʻia ʻana o ka monolabeled paena, wehewehe i ka stoichiometry i manaʻo ʻia a me ka laulā ʻae ʻia; ʻO ka hopena lepili like ʻole paha e pono ai ka puʻunaue a i ʻole ke degere awelika o ka lepili. E koho i nā ala ʻike e pili ana i ke kaʻina a me ka hoʻokomo lepili, a hoʻohui i nā koi microbial inā pili.
Hoʻonui ka hoʻohana hou ʻana i ka pae ma luna o ka nui-a-lot. A 2026 loiloi o multianalyte nano-biosensors hōʻike electrode regeneration hiki a hiki i 50 hoʻohana hou i nā pōʻai me ka ʻokoʻa maʻamau ma lalo 0.82%, a 25 nā pōʻaiapili hou me ka ʻole o ka nalowale o ka naʻau i loko o kahi paepae impedance microfluidic (Bioeng Biotechnol i mua, 2025). ʻO kahi mea ʻike i hana hou ʻia he kanalima mau manawa e hoʻonui ai i ka neʻe ʻana i ka helu lepili a i ʻole ka māhele kūlana, no laila ʻoi aku ka paʻa o kāu pae degere-o-lepili, ʻoi aku ka nui o nā pōʻai hiki iā ʻoe ke hilinaʻi.
E hoʻokuʻu i ka noiʻi kū'ē i ka pono, nā pae hoʻohālikelike hoʻāʻo a me kahi hoʻolālā ʻike kūpono. Nuipa paʻa, He palena ʻokoʻa ko MS/MS a me nā ʻano haku mele; ʻAʻole hoʻokumu ʻia ka hōʻailona amino-acid wale nō i ke kūlana lepili a i ʻole ka hoʻonohonoho ʻana. Pono ka loiloi analytical e hoʻoholo.
Nīnau pinepine
He aha ke ʻano o ka hoʻopaʻa inoa ʻana a no ke aha e pono ai i kahi laulā?
ʻO ke kiʻekiʻe o ka hoʻopaʻa inoa ʻana ka helu awelika o nā molekole lepili i kēlā me kēia peptide. Pono ia i ka laulā no ka mea he awelika: he waiwai o 1.0 hiki ke hūnā i ka hui ʻana o nā ʻano ʻano lepili ʻole ʻia a papalua, no laila e wehewehe pū ka laulā me ka kikoʻī kūlana i kāu mea maoli.
Hiki iaʻu ke hoʻopaʻa inoa i kahi peptide i ʻoi aku ma mua o hoʻokahi cysteine?
ʻAe, akā pono ʻoe e hoʻoholo pehea. Hiki iā ʻoe ke pale i nā cysteine ʻē aʻe i ka wā synthesis, hoʻohana i ka hui helu helu a ʻae i ka puʻunaue, a i ʻole e koho i kahi koho kemika no kahi kaiapuni. Inā makemake ʻoe i kahi conjugate i wehewehe ʻia, e haʻi aku i ka mea hoʻolako i ka cysteine i ka pahuhopu a manaʻo e hoʻopaʻa ʻia nā mea ʻē aʻe.
ʻOi aku ka maʻemaʻe HPLC kiʻekiʻe e hōʻoiaʻiʻo i ka hana sensor ʻoi aku ka maikaʻi?
ʻAʻole. Hōʻike ka hoʻomaʻemaʻe iā ʻoe i ka nui o nā mea i ke kaʻina pahuhopu, ʻaʻole inā aia ka lepili, kahi e noho ai, a i ʻole ka nui o ka peptide i loko o ka vial. ʻO ka hana Assay e pili ana i ka kikoʻī piha, a ʻo ka papa maʻemaʻe he hui pāʻoihana ma mua o ka paepae hana i hōʻoia ʻia.
Pehea wau e wehewehe ai i ka palapala counterion?
E hōʻike maopopo i ke ʻano paʻakai ma ka ʻōlelo kikoʻī, me nā hoʻololi āu e pono ai, e like me ka trifluoroacetate i ka acetate. E noi i ka maʻiʻo counterion a me ka ʻike wai e like me nā hopena hoʻokuʻu, no ka mea, pili nā mea ʻelua i kou kaumaha a hoʻopau i ka peptide.
Ka hopena
ʻO kā mākou manaʻo e kākau i ka kikoʻī a puni nā ʻano ʻelima, e hoʻopaʻa i kēlā me kēia i kahi ala i hōʻoia ʻia, a hoʻokuʻu wale ma ka pūʻolo pili. Ma kahi āu e maopopo ʻole ai i ka loulou kūpono a i ʻole ke kūlana lepili, e noi i ka ʻōlelo aʻoaʻo me ke kumu i hoʻopili ʻia ma mua o ka hoʻopaʻa ʻole ʻana i kahi mea papa inoa. Inā loaʻa iā ʻoe kahi kaʻina a me kahi koi lepili, e hoʻouna iā lākou i kā mākou hui no ka loiloi kūpono a e haʻi mākou iā ʻoe i ka mea e ʻae ai ka chemistry a me ka mea e hōʻike ʻia e ka palapala..
Hōʻike ka mea hoʻopuka: Hāʻawi ʻo MOL Changes i nā lawelawe peptide a he hoihoi koʻikoʻi i kēia kumuhana. ʻO nā lālā lawelawe a me nā ʻōlelo hiki ke koi i nā mea hoʻolako; ʻO ka loaʻa a me ka hana ʻana no kahi kūkulu kikoʻī e koi i nā hōʻike kikoʻī o ka papahana.
Luna ʻenehana Nui; ʻO ka mea akamai i ka peptide SynthesisKaʻike kumu: ʻO ka peptide synthesis paʻakikī, nā hoʻololi ʻana o ka amino acid kūlohelohe, a me ke kūkulu ʻana i nā peptides cyclic a me nā peptides stapled.
moʻokalaleo:He ʻike nui ʻo Zejun Peng i ka kemika kūlohelohe a me ka synthesis peptide. Maikaʻi ʻo ia i ka hoʻohana ʻana o ka solid-phase peptide synthesis (SPSS) a me ka peptide synthesis wai (LPPS), a akamai loa i ka lanakila ʻana i nā "paʻakikī loa-e-synthesize sequences" (e like me nā peptides ultra-long-chain, nā kaʻina hydrophobic kiʻekiʻe, a me ka pelu ana i na mea paa disulfide lehulehu). Ma lalo o kāna alakaʻi, ua lanakila ka hui i nā bottlenecks ʻenehana i kekahi mau hoʻololi kūikawā (e like me ka N-methylation, PEGylation, a me ka lepili fluorescent), ka mālama ʻana i ka helu kūleʻa synthesis o luna 98%.
🟢 Online · Pane i loko o 24h · Peptide Synthesis & CRO
MC
Aloha 👋 Welina mai iā MOL Changes
E haʻi mai iā mākou i kāu mea e pono ai - sequence, ka maemae, ka nui a i ʻole assay - a e pane kā mākou hui synthesis me kahi ʻōlelo kikoʻī i loko o hoʻokahi lā ʻoihana. ʻAʻole pono ka uku pūnaewele.